Racial disparity seen in initiation of newer diabetes meds
Feb 01, 2022
Significantly lower rates of initiation were seen in Black and American Indian or Alaskan Native individuals.
Consensus statement defines remission of type 2 diabetes
Sep 07, 2021
Remission is defined as HbA1c <6.5% for at least three months after cessation of glucose-lowering pharmacotherapy.
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
Antidepressant use may aid outcomes in depression and diabetes
Jul 23, 2021
Regular versus poor antidepressant use was tied to a lower risk for advanced diabetic complications and mortality in patients with depression and diabetes.
Medication type for diabetes may affect severe COVID-19 outcomes
Jun 30, 2021
Premorbid GLP1-RA use, SGLT2i use were associated with lower 60-day mortality compared to premorbid DPP4i use.
SGLT2 inhibitors may cut risk for heart failure hospitalization
Sep 28, 2021
SGLT2 inhibitors, compared with GLP-1 RAs, linked to lower risk for heart failure hospitalization in patients with T2DM, with or without cardiovasular disease.
Newly diagnosed diabetes at COVID-19 admission profiled
Mar 02, 2022
Lower levels of glucose and HbA1c, and higher levels of inflammatory markers, were seen in COVID-19 patients with newly diagnosed diabetes mellitus versus preexisting diabetes.
Monoclonal antibody therapy may cut COVID-19 hospitalizations
Aug 31, 2021
Lower hospitalization rates were seen at 14, 21 and 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab.
More steps per day may cut risk for incident diabetes in seniors
Jan 27, 2022
“It’s not enough for somebody to go on a walk once a week,” the lead author said in a statement. “Our study indicates that regular stepping is indicative of lower diabetes risk...
Whole-fruit intake may reduce risk for Type 2 diabetes
Jun 08, 2021
Total fruit intake is inversely associated with serum insulin and HOMA2 of ß-cell function